Niall O'Donnell
QuietNamed in filings at RivervestOn the current fund
- Board seats filed
- 9
- Named on a board
- 0
all filings on record
Named in filings at RivervestOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Sparrow Pharmaceuticals | Biotech & pharma | April 2024 | Orbimed Asia Partners, Orbimed Genesis, U.S Venture Partners |
| Mirum Pharmaceuticals | Biotech & pharma | December 2020 | NEA |
| Wugen | Not yet classified | April 2020 | None on file |
| SPRUCE BIOSCIENCES | Not yet classified | February 2020 | None on file |
| Curzion Pharmaceuticals | Biotech & pharma | March 2019 | NEA |
| Reneo Pharmaceuticals | Biotech & pharma | December 2017 | NEA |
| Avalyn Pharma | Not yet classified | March 2017 | None on file |
| Amplyx Pharmaceuticals | Biotech & pharma | October 2015 | NEA, Sofinnova Venture Partners |
| Lyric Pharmaceuticals | Not yet classified | February 2015 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Niall O'Donnell on the board, based on 5 filed seats with a verified or cited source.
4 more filed seats not yet classified, left out of the shares above.